As ASF bacteria colonization has reduced T1D in GF MyD88-deficient NOD mice, it is possible that several signaling pathways activated by TLR agonists could contribute to protection when MyD88 signaling is absent. Here, MYD88 is linked to type 1 diabetes mellitus.